ÖÐÎÄÃû³Æ£º LRRC19 ¿¹Ô£¨ÖØ×éµ°°×£©
Ó¢ÎÄÃû³Æ£º LRRC19 Antigen (Recombinant Protein)
±ð Ãû£º leucine rich repeat containing 19
Ïà¹ØÀà±ð£º ¿¹Ô
¸Å Êö
|
Fusion protein corresponding to a region derived from 171-370 amino acids of human LRRC19 |
|
Full name: |
leucine rich repeat containing 19 |
|
Swissprot: |
Q9H756 |
|
Gene Accession: |
BC126156 |
|
Purity: |
>85%, as determined by Coomassie blue stained SDS-PAGE |
|
Expression system: |
Escherichia coli |
|
Tags: |
His tag C-Terminus, GST tag N-Terminus |
|
Background: |
LRRC19 is a member of the extracellular leucine-rich repeat superfamily, a family of proteins that are thought to have diverse functions such as cell adhesion, signaling, and innate immunity. LRRC19 is closely related to the Toll-like receptors (TLRs), especially TLR3. LRRC19 does not contain a cytoplasmic Toll/IL-1 receptor (TIR) domain, but can activate NF-kappaB and induce the production of proinflammatory cytokines after stimulation with the TLR3 and other TLR ligands, suggesting that LRRC19 may play a role in the recognition and the response to certain pathogenic microorganisms. LRRC19 has also been suggested to be a potential biomarker for pancreatic tumor sensitivity to the anti-cancer, small molecule Src inhibitor AZD0530. |
¹ºÎï³µ
°ïÖú
021-54845833/15800441009
